Found: 5
Select item for more details and to access through your institution.
Glycolysis inhibition for anticancer treatment.
- Published in:
- Oncogene, 2006, v. 25, n. 34, p. 4633, doi. 10.1038/sj.onc.1209597
- By:
- Publication type:
- Article
Loss of p53 and altered miR15-a/16-1MCL-1 pathway in CLL: insights from TCL1-Tg:p53(-/-) mouse model and primary human leukemia cells.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Loss of p53 and altered miR15-a/16-1MCL-1 pathway in CLL: insights from TCL1-Tg:p53<sup>−/−</sup> mouse model and primary human leukemia cells.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 1, p. 118, doi. 10.1038/leu.2013.125
- By:
- Publication type:
- Article
Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-C.
- Published in:
- Leukemia (08876924), 2006, v. 20, n. 4, p. 610, doi. 10.1038/sj.leu.2404140
- By:
- Publication type:
- Article
Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cells.
- Published in:
- Leukemia (08876924), 2005, v. 19, n. 12, p. 2153, doi. 10.1038/sj.leu.2403968
- By:
- Publication type:
- Article